1. Home
  2. AUDC vs LCTX Comparison

AUDC vs LCTX Comparison

Compare AUDC & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

N/A

Current Price

$8.56

Market Cap

247.7M

Sector

Utilities

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$0.78

Market Cap

251.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AUDC
LCTX
Founded
1992
1990
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.7M
251.4M
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
AUDC
LCTX
Price
$8.56
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $5.50
AVG Volume (30 Days)
115.0K
★ 2.1M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
★ 4.44%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $14,556,000.00
Revenue This Year
$3.05
$4.38
Revenue Next Year
$3.87
$10.80
P/E Ratio
$23.06
★ N/A
Revenue Growth
N/A
★ 53.24
52 Week Low
$6.95
$0.77
52 Week High
$11.74
$1.99

Technical Indicators

Market Signals
Indicator
AUDC
LCTX
Relative Strength Index (RSI) 36.29 34.81
Support Level $8.27 N/A
Resistance Level $9.17 $1.16
Average True Range (ATR) 0.49 0.08
MACD -0.01 -0.03
Stochastic Oscillator 34.19 2.86

Price Performance

Historical Comparison
AUDC
LCTX

About AUDC AudioCodes Ltd.

AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: